BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 20539907)

  • 1. Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases.
    Lian Q; Chow Y; Esteban MA; Pei D; Tse HF
    Thromb Haemost; 2010 Jul; 104(1):39-44. PubMed ID: 20539907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cells: a new technology to study human diseases.
    Vitale AM; Wolvetang E; Mackay-Sim A
    Int J Biochem Cell Biol; 2011 Jun; 43(6):843-6. PubMed ID: 21458591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
    Li Y; Geng YJ
    Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: insights from experimental models.
    Kong CW; Akar FG; Li RA
    Thromb Haemost; 2010 Jul; 104(1):30-8. PubMed ID: 20539906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
    Murata M; Tohyama S; Fukuda K
    Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting pluripotency for therapeutic gain.
    Deng W
    Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An introduction to induced pluripotent stem cells.
    Hanley J; Rastegarlari G; Nathwani AC
    Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.
    Grabel L
    J Cell Biochem; 2012 Feb; 113(2):381-7. PubMed ID: 21928325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.
    Song M; Paul S; Lim H; Dayem AA; Cho SG
    Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
    Pan G; Wang T; Yao H; Pei D
    Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cells: an emerging theranostics platform.
    Nelson TJ; Terzic A
    Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells.
    Pick M; Stelzer Y; Bar-Nur O; Mayshar Y; Eden A; Benvenisty N
    Stem Cells; 2009 Nov; 27(11):2686-90. PubMed ID: 19711451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promise of human induced pluripotent stem cells for research and therapy.
    Nishikawa S; Goldstein RA; Nierras CR
    Nat Rev Mol Cell Biol; 2008 Sep; 9(9):725-9. PubMed ID: 18698329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New era of regenerative medicine for cardiovascular diseases.
    Tse HF
    Thromb Haemost; 2010 Jul; 104(1):4-5. PubMed ID: 20539908
    [No Abstract]   [Full Text] [Related]  

  • 17. Reprogramming adult hematopoietic cells.
    Kaneko S; Otsu M; Nakauchi H
    Curr Opin Hematol; 2010 Jul; 17(4):271-5. PubMed ID: 20571391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming of somatic cells.
    Rajasingh J
    Prog Mol Biol Transl Sci; 2012; 111():51-82. PubMed ID: 22917226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
    Iglesias-García O; Pelacho B; Prósper F
    J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.